Literature DB >> 5015290

Assessment of the need for continued oral therapy in diabetics.

A M Tomkins, A Bloom.   

Abstract

Hypoglycaemic agents were replaced by placebos in diabetic patients attending a hospital clinic. Of 62 patients observed, 43 (69%) relapsed within six months but blood sugar control remained unchanged in 19 (31%) during the period of observation.

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 5015290      PMCID： PMC1787772          DOI： 10.1136/bmj.1.5801.649

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


  3 in total

1.  Tolbutamide in diabetes; some clinical and biochemical studies.

Authors:  M F CROWLEY; F W WOLFF; A BLOOM
Journal:  Br Med J       Date:  1957-08-10

2.  Is the use of sulphonylurea derivatives in the treatment of diabetes mellitus dangerous?

Authors:  G R Constam
Journal:  Diabetologia       Date:  1971-08       Impact factor: 10.122

3.  Blood-sugar and arterial disease.

Authors:  H Keen; G Rose; D A Pyke; D Boyns; C Chlouverakis
Journal:  Lancet       Date:  1965-09-11       Impact factor: 79.321
  3 in total
  7 in total

1.  Trial of placebo in long-term chlorpropamide-treated diabetics.

Authors:  A Lev-Ran
Journal:  Diabetologia       Date:  1974-06       Impact factor: 10.122

2.  A selected public health bibliography with annotations.

Authors:  C M Wylie
Journal:  Am J Public Health       Date:  1972-06       Impact factor: 9.308

3.  Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone.

Authors:  P H Sönksen; C Lowy; J R Perkins; T E West
Journal:  Diabetologia       Date:  1981       Impact factor: 10.122

Review 4.  Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 2.

Authors:  J E Jackson; R Bressler
Journal:  Drugs       Date:  1981-10       Impact factor: 9.546

5.  An audit of the care of diabetics in a group practice.

Authors:  B J Doney
Journal:  J R Coll Gen Pract       Date:  1976-10

Review 6.  Oral hypoglycaemic agents. An update.

Authors:  A C Asmal; A Marble
Journal:  Drugs       Date:  1984-07       Impact factor: 9.546

7.  Wide variation in serum chlorpropamide concentration in outpatients.

Authors:  U Bergman; I Christenson; B Jansson
Journal:  Eur J Clin Pharmacol       Date:  1980-08       Impact factor: 2.953
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.